224 related articles for article (PubMed ID: 29187387)
21. Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study.
Motiwala SR; Szymonifka J; Belcher A; Weiner RB; Baggish AL; Sluss P; Gaggin HK; Bhardwaj A; Januzzi JL
Eur J Heart Fail; 2013 Oct; 15(10):1157-63. PubMed ID: 23666680
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of serum galectin-3 levels in patients with acute heart failure with preserved ejection fraction.
Carrasco-Sánchez FJ; Aramburu-Bodas O; Salamanca-Bautista P; Morales-Rull JL; Galisteo-Almeda L; Páez-Rubio MI; Arias-Jiménez JL; Aguayo-Canela M; Pérez-Calvo JI
Int J Cardiol; 2013 Nov; 169(3):177-82. PubMed ID: 24207066
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study.
Lok DJ; Van Der Meer P; de la Porte PW; Lipsic E; Van Wijngaarden J; Hillege HL; van Veldhuisen DJ
Clin Res Cardiol; 2010 May; 99(5):323-8. PubMed ID: 20130888
[TBL] [Abstract][Full Text] [Related]
24. Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction.
de Boer RA; Lok DJ; Jaarsma T; van der Meer P; Voors AA; Hillege HL; van Veldhuisen DJ
Ann Med; 2011 Feb; 43(1):60-8. PubMed ID: 21189092
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic and prognostic accuracy of galectin-3 and soluble ST2 for acute heart failure.
Mueller T; Gegenhuber A; Leitner I; Poelz W; Haltmayer M; Dieplinger B
Clin Chim Acta; 2016 Dec; 463():158-164. PubMed ID: 27983996
[TBL] [Abstract][Full Text] [Related]
26. Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT.
Anand IS; Rector TS; Kuskowski M; Adourian A; Muntendam P; Cohn JN
Eur J Heart Fail; 2013 May; 15(5):511-8. PubMed ID: 23291728
[TBL] [Abstract][Full Text] [Related]
27. Triple head-to-head comparison of fibrotic biomarkers galectin-3, osteopontin and gremlin-1 for long-term prognosis in suspected and proven acute heart failure patients.
Behnes M; Bertsch T; Weiss C; Ahmad-Nejad P; Akin I; Fastner C; El-Battrawy I; Lang S; Neumaier M; Borggrefe M; Hoffmann U
Int J Cardiol; 2016 Jan; 203():398-406. PubMed ID: 26539964
[TBL] [Abstract][Full Text] [Related]
28. Galectin-3 as a marker for clinical prognosis and cardiac remodeling in acute heart failure.
Lala RI; Lungeanu D; Darabantiu D; Pilat L; Puschita M
Herz; 2018 Mar; 43(2):146-155. PubMed ID: 28235980
[TBL] [Abstract][Full Text] [Related]
29. HE4 Serum Levels Are Associated with Heart Failure Severity in Patients With Chronic Heart Failure.
Piek A; Meijers WC; Schroten NF; Gansevoort RT; de Boer RA; Silljé HH
J Card Fail; 2017 Jan; 23(1):12-19. PubMed ID: 27224553
[TBL] [Abstract][Full Text] [Related]
30. Galectin-3 is independently associated with cardiovascular mortality in community-dwelling older adults without known cardiovascular disease: The Rancho Bernardo Study.
Daniels LB; Clopton P; Laughlin GA; Maisel AS; Barrett-Connor E
Am Heart J; 2014 May; 167(5):674-82.e1. PubMed ID: 24766977
[TBL] [Abstract][Full Text] [Related]
31. The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Gullestad L; Ueland T; Kjekshus J; Nymo SH; Hulthe J; Muntendam P; McMurray JJ; Wikstrand J; Aukrust P
Am Heart J; 2012 Dec; 164(6):878-83. PubMed ID: 23194488
[TBL] [Abstract][Full Text] [Related]
32. Meta-Analysis of the Usefulness of Plasma Galectin-3 to Predict the Risk of Mortality in Patients With Heart Failure and in the General Population.
Imran TF; Shin HJ; Mathenge N; Wang F; Kim B; Joseph J; Gaziano JM; Djoussé L
Am J Cardiol; 2017 Jan; 119(1):57-64. PubMed ID: 28247849
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of plasma galectin-3 levels in patients with coronary heart disease and chronic heart failure.
Yu X; Sun Y; Zhao Y; Zhang W; Yang Z; Gao Y; Cai H; Li Y; Wang Q; Bian B; Nie J
Int Heart J; 2015 May; 56(3):314-8. PubMed ID: 25902879
[TBL] [Abstract][Full Text] [Related]
34. Metabolic profile provides prognostic value better than galectin-3 in patients with heart failure.
Wang CH; Cheng ML; Liu MH; Kuo LT; Shiao MS
J Cardiol; 2017 Jul; 70(1):92-98. PubMed ID: 28318874
[TBL] [Abstract][Full Text] [Related]
35. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community.
Ho JE; Liu C; Lyass A; Courchesne P; Pencina MJ; Vasan RS; Larson MG; Levy D
J Am Coll Cardiol; 2012 Oct; 60(14):1249-56. PubMed ID: 22939561
[TBL] [Abstract][Full Text] [Related]
36. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
[TBL] [Abstract][Full Text] [Related]
37. Exploring the Prognostic Value of Novel Markers in Adults With a Systemic Right Ventricle.
Geenen LW; van Grootel RWJ; Akman K; Baggen VJM; Menting ME; Eindhoven JA; Cuypers JAAE; Boersma E; van den Bosch AE; Roos-Hesselink JW
J Am Heart Assoc; 2019 Sep; 8(17):e013745. PubMed ID: 31431113
[TBL] [Abstract][Full Text] [Related]
38. Research on clinical value of galectin-3 in evaluating the prognosis of acute heart failure.
Zhang T; Shao B; Liu GA
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4406-4410. PubMed ID: 29077153
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of growth differentiation factor-15 in Chinese patients with heart failure: A prospective observational study.
Wang H; Chen Q; Li Y; Jing X; Yang J
Cardiol J; 2018; 25(2):245-253. PubMed ID: 28612904
[TBL] [Abstract][Full Text] [Related]
40. Role of galectin-3 and plasma B type-natriuretic peptide in predicting prognosis in discharged chronic heart failure patients.
Feola M; Testa M; Leto L; Cardone M; Sola M; Rosso GL
Medicine (Baltimore); 2016 Jun; 95(26):e4014. PubMed ID: 27368017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
